4574 Stock Overview
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Taiko Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥332.00 |
| 52 Week High | JP¥420.00 |
| 52 Week Low | JP¥263.00 |
| Beta | 0.089 |
| 1 Month Change | -14.43% |
| 3 Month Change | 9.21% |
| 1 Year Change | -12.86% |
| 3 Year Change | -72.56% |
| 5 Year Change | -45.15% |
| Change since IPO | 18.57% |
Recent News & Updates
Is Taiko PharmaceuticalLtd (TSE:4574) A Risky Investment?
Mar 08
Taiko Pharmaceutical Co.,Ltd. (TSE:4574) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 08Shareholder Returns
| 4574 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -7.5% | -2.2% | -4.7% |
| 1Y | -12.9% | 8.6% | 26.3% |
Return vs Industry: 4574 underperformed the JP Medical Equipment industry which returned 8.6% over the past year.
Return vs Market: 4574 underperformed the JP Market which returned 26.3% over the past year.
Price Volatility
| 4574 volatility | |
|---|---|
| 4574 Average Weekly Movement | 8.9% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.2% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 4574 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4574's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 208 | Takashi Shibata | www.seirogan.co.jp |
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally. The company provides OTC medicines for the treatment of loose stools, diarrhea, vomiting, food and water poisoning symptoms, and toothache; and quasi-drugs for regulation of intestinal movements, relieves stomach distention, loose stools, and constipation.
Taiko Pharmaceutical Co.,Ltd. Fundamentals Summary
| 4574 fundamental statistics | |
|---|---|
| Market cap | JP¥16.68b |
| Earnings (TTM) | -JP¥3.61b |
| Revenue (TTM) | JP¥6.12b |
2.7x
P/S Ratio-4.6x
P/E RatioIs 4574 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4574 income statement (TTM) | |
|---|---|
| Revenue | JP¥6.12b |
| Cost of Revenue | JP¥3.54b |
| Gross Profit | JP¥2.58b |
| Other Expenses | JP¥6.19b |
| Earnings | -JP¥3.61b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | -72.11 |
| Gross Margin | 42.11% |
| Net Profit Margin | -59.00% |
| Debt/Equity Ratio | 47.6% |
How did 4574 perform over the long term?
See historical performance and comparison